Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
BMJ Open Gastroenterology
|
February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Edouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research
|
April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis
|
March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease
Axel Dignass, Neeraj Narula, Krishan Pratap, et al.
The American Journal of Gastroenterology
|
December 29, 2022
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study
Christopher Ma, Remo Panaccione, Yasi Xiao, et al.
The American Journal of Gastroenterology
|
November 12, 2024
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease
Dina Kao, Karen Wong, Humberto Jijon, et al.
The American Journal of Gastroenterology
|
May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors
Parambir S Dulai, Robert Battat, Maria Barsky, et al.
Journal of Crohn'S & Colitis
|
November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis
Virginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
The American Journal of Gastroenterology
|
June 5, 2025
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
Virginia Solitano, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.
Journal of Crohn'S & Colitis
|
February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
BMJ Open Gastroenterology
|
February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Edouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research
|
April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis
|
March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease
Axel Dignass, Neeraj Narula, Krishan Pratap, et al.
The American Journal of Gastroenterology
|
December 29, 2022
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study
Christopher Ma, Remo Panaccione, Yasi Xiao, et al.
The American Journal of Gastroenterology
|
November 12, 2024
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease
Dina Kao, Karen Wong, Humberto Jijon, et al.
The American Journal of Gastroenterology
|
May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors
Parambir S Dulai, Robert Battat, Maria Barsky, et al.
Journal of Crohn'S & Colitis
|
November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis
Virginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
The American Journal of Gastroenterology
|
June 5, 2025
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
Virginia Solitano, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.
Journal of Crohn'S & Colitis
|
February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Page
of 21